Agati Clinical Company Profile

Background

Overview

Agati Clinical is a rapidly growing global life sciences services company specializing in providing high-quality, on-time clinical operations, data management, standardization, and statistical analysis services. Established in 2013, Agati Clinical offers customized clinical staffing solutions and specialized clinical data services, including Data Management, Data Standardization (CDISC), Biostatistics, Statistical Programming, and Regulatory Services (Submissions Publishing, eCTD Packaging, SPL Submissions, Labeling, and Artwork Management) across all phases of clinical development to pharmaceutical, biotechnology, and medical device companies.

Mission and Vision

Agati Clinical's mission is to enable enterprises by offering superior performance and cost efficiencies. The company's vision is to become one of the top five clinical data services organizations globally by being the most dependable partner for pharmaceuticals, biotech, and CRO partners in delivering value-added services.

Industry Significance

Agati Clinical plays a crucial role in the life sciences industry by providing comprehensive clinical data and regulatory submission services. Its expertise supports pharmaceutical, biotechnology, and medical device companies in navigating complex clinical development processes, ensuring compliance with regulatory standards, and enhancing operational efficiencies.

Key Strategic Focus

Core Objectives

Agati Clinical aims to deliver high-quality, on-time clinical data and analysis services with delivery models that offer up to 40% cost efficiency.

Areas of Specialization

Clinical Resource Solutions: Providing flexible, strategic clinical staffing solutions tailored to client needs, including placement of CRAs, CTMs, Project Managers, Study Start-up Specialists, and other critical roles.

Medical Writing: Offering clear, concise, and high-quality medical writing services supported by a strong academic and industry background.

Functional Services 360: Implementing the FSP model to separate core/non-core capabilities within client organizations, allowing for specialized providers in disciplines such as Statistical Programming, Biostatistics, Data Management, Regulatory, and Pharmacovigilance.

Statistical Programming & Biostatistics: Assisting in the analysis of various clinical trials, including parallel, crossover, multi-phase, and PK/PD studies, adhering to SOPs and ICH guidelines.

Regulatory Submission: Ensuring comprehensive fulfillment of pharmaceutical companies' submission publishing requirements, including navigating FDA’s eDRL SPL process with guaranteed 100% accuracy.

Clinical Software Development: Providing in-depth IT expertise across various platforms and domains to execute end-to-end application design needs efficiently.

Data Management: Offering experienced data management teams capable of working on any EDC platform and bespoke customer platforms, ensuring total customer satisfaction.

Pharmacovigilance: Delivering end-to-end services in pharmacovigilance KPO, handling annual volumes of more than 100,000 cases with metrics-driven delivery from strategic global locations.

Key Technologies Utilized

Agati Clinical employs a metadata-driven standardization approach for clinical trial data, ensuring quality deliverables in the shortest possible time with significant cost savings.

Primary Markets Targeted

The company primarily serves pharmaceutical, biotechnology, and medical device companies, providing solutions across all phases of clinical development.

Financials and Funding

Funding History

As of the latest available information, Agati Clinical has not publicly disclosed specific details regarding its funding history, total funds raised, or recent funding rounds.

Notable Investors

There is no publicly available information regarding notable investors in Agati Clinical.

Utilization of Capital

Specific details regarding the intended utilization of capital have not been publicly disclosed.

Pipeline Development

Key Pipeline Candidates

Agati Clinical specializes in providing clinical data and regulatory submission services across all phases of clinical development. While the company does not develop its own pharmaceutical products, it supports clients in the development of their pipeline candidates.

Stages of Clinical Trials

Agati Clinical offers services across all phases of clinical development, including preclinical, Phase I, Phase II, Phase III, and post-marketing studies.

Target Conditions

The company supports a wide range of therapeutic areas, aligning with current market demand and client needs. Specific target conditions are not publicly detailed.

Anticipated Milestones

As a service provider, Agati Clinical's milestones are typically aligned with client project timelines and regulatory submission schedules.

Technological Platform and Innovation

Proprietary Technologies

Agati Clinical specializes in the standardization of clinical trial data in CDISC standards or sponsor-defined standards, utilizing a metadata-driven standardization approach to ensure quality deliverables efficiently.

Significant Scientific Methods

The company employs a metadata-driven standardization approach for clinical trial data, ensuring quality deliverables in the shortest possible time with significant cost savings.

AI-Driven Capabilities

Specific details regarding AI-driven capabilities are not publicly disclosed.

Leadership Team

Key Executives

Ramanan Bathala: CEO and Founder of Agati Group, leading the company's strategic direction and operations.

Sathiya Vivegan Nagarathinam: Designated Partner at Agati Clinical Informatics LLP, involved in the company's leadership and decision-making processes.

Professional Backgrounds

Detailed professional backgrounds of the leadership team are not publicly disclosed.

Key Contributions

The leadership team has been instrumental in expanding Agati Clinical's service offerings and establishing strategic partnerships, such as the acquisition by Clinscience US LLC, a subsidiary of Neuca Group, in April 2022.

Leadership Changes

Recent Appointments

In April 2022, Clinscience US LLC acquired a 51% stake in Agati Systems, the parent company of Agati Clinical, marking a significant development in the company's leadership and strategic direction.

Competitor Profile

Market Insights and Dynamics

The clinical data services market is characterized by a growing demand for efficient and cost-effective solutions in clinical trials. Companies like Agati Clinical are well-positioned to capitalize on this trend by offering specialized services that enhance operational efficiencies and ensure regulatory compliance.

Competitor Analysis

Agati Clinical operates in a competitive landscape with several key players offering similar services. Notable competitors include Clinscience, which acquired a majority stake in Agati Systems in April 2022, and other global life sciences service providers.

Strategic Collaborations and Partnerships

The acquisition by Clinscience US LLC in April 2022 has strengthened Agati Clinical's market position, providing access to Clinscience's Data Management & Biostatistics Team and enhancing its service offerings.

Operational Insights

Agati Clinical differentiates itself through its flexible, strategic clinical staffing solutions and a comprehensive suite of services that address various aspects of clinical development, from data management to regulatory submissions.

Strategic Opportunities and Future Directions

The partnership with Clinscience presents opportunities for Agati Clinical to expand its service offerings, integrate advanced data-driven solutions, and enhance its global presence in the clinical data services market.